|
|||||
|
|
Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia |
|
| Authors: | Jalpa A. Doshi Pengxiang Li Sunita Desai Steven C. Marcus |
| Affiliation: | 1. Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA;2. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA;3. Department of Population Health, Division of Health Care Delivery Science, NYU School of Medicine, New York, USA (Wharton School, University of Pennsylvania, Philadelphia, PA at the time of the study);4. School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, USA |
| Abstract: | |
| Keywords: | Medicaid copayments anti-psychotics schizophrenia out-of-pocket costs |